Dr Menachem is a cardiologist based in Nashville, Tennessee.
Dr Menachem graduated with anMD from Tulane University School of Medicine in 2010. He completed his residency in 2013 at Duke University and a fellowship in general cardiology at the Hospital of the University of Pennsylvania in 2017.
Dr Menachem currently works as the Director of Advanced Congenital Cardiac Therapies (ACCT) at the Vanderbilt University Medical Center, a position he has held since 2017.2 He is the author and co-author of over 80 research publications. He is focused on transplant cardiology and advanced therapies for adults with congenital heart disease (ACHD). His research has focused on mechanical support in patients with transposition of the great vessels, as well as transplantation in patients with complex congenital heart disease.3
- 1996 - 2000: BS, Economics, Duke University
- 2006 - 2010; MD, Tulane University School of Medicine
- 2010 - 2013: Residency, Internal Medicine, Duke University
- 2013 - 2017: Fellowship, General Cardiology, Hospital of the University of Pennsylvania
- 2016 - 2021: Member Board Of Directors, Shock Analytics
- 2016 - 2021: Strategic Advisor, Castleman Disease Collaborative Network
- 2017 - Present: Heart Failure and Transplantation Program, Director - Advanced Congenital Cardiac Therapies (ACCT), Vanderbilt University Medical Center
2013: Internal Medicine - American Board of Internal Medicine
2016: Cardiovascular Disease - American Board of Internal Medicine
2018: Advanced Heart Failure and Transplant Cardiology - American Board of Internal Medicine